Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Survivors of uterine cancer are at higher risk of experiencing cardiovascular problems years after treatment.
Lenvatinib plus pembrolizumab has shown promise in patients with advanced endometrial cancer, regardless of tumor MSI status.
True or false: The staging system developed by the International Federation of Obstetrics and Gynecology (FIGO) is the most frequently utilized staging system for endometrial cancer.
True or False: Many risk factors for endometrial cancer are related to ___.
True or false: DNA repair pathways are often altered in endometrial cancer.
Endometrial cancers account for ___ of all uterine cancers.
In the past 10 years, death rates from endometrial cancers have increased by ___.
True or false: Options for systemic therapy in advanced or recurrent endometrial cancer include chemotherapy, immunotherapy/biologic therapy, and hormone therapy.